EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement

Ayush Pant iD, Michael Lim

Cancers · 16.02.2023 · 15 (4) · 1249

DOI: 10.3390/cancers15041249 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.02.2023. Verfasst von Ayush Pant und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21218, USA. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Completed clinical trials of CAR-T cells in glioblastoma (GBM) have revealed key challenges that limit their efficacy. These include incomplete antigen coverage, downregulation of target antigen in response to therapy, exposure to immunosuppressive cells and cytokines in the tumor microenvironment and exhaustion of CAR-T cells. To overcome these challenges, CAR-T cells have been modified to maximize effector function and resist immunosuppression in the tumor while limiting toxicities to the host. Adoption of these novel CAR-T strategies in GBM can overcome the “cold tumor” phenotype of GBM and trigger an inflammatory cascade that maximizes tumor clearance and minimizes CAR-T dysfunction. To achieve this, understanding and harnessing the antigenic, metabolic and immunological composition of GBM is crucial. Here we review the findings from completed clinical trials of CAR-T cells in GBM as well as novel strategies that could improve CAR-T survival and function in the tumor.

Schlagwörter

Stichwörter der Autor:innen

CAR-T cellsexhaustionglioblastomaimmunosuppressionimmunotherapy

Autor:innen und Institutionen

  • Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21218, USA.
  • Department of Neurosurgery, School of Medicine, Stanford University, Stanford, CA 94305, USA.

ORCID-Profile: Ayush Pant

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Pant, A., & Lim, M. (2023). CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement. Cancers, 15(4), 1249. https://doi.org/10.3390/cancers15041249

Vancouver

Pant A, Lim M. CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement. Cancers. 2023;15(4):1249. doi:10.3390/cancers15041249

BibTeX
@article{Pant2023,
  author = {Pant, Ayush and Lim, Michael},
  title = {CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1249},
  doi = {10.3390/cancers15041249}
}
Kostenlos starten →